Study to Assess the Safety and Efficacy of SelK2 on Airway Responses Following Allergen Challenge in Subjects With Asthma (Part 1) and in Subjects With Chronic Obstructive Pulmonary Disease (Part 2)
Clinical trial NCT04540042 · COMPLETED
Trial details
- NCT number
- NCT04540042
- Sponsor
- Tetherex Pharmaceuticals Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-18
- Primary completion
- 2021-12-21
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.